Atul Bedi
Impact in
- Cancer Research top 0.5%
- Cancer, Hypoxia, and Metabolism
- NF-κB Signaling Pathways
- Oncology top 2%
- Cancer-related Molecular Pathways
Papers in
- Oncology 17
- Cancer-related Molecular Pathways 8
- Colorectal Cancer Treatments and Studies 4
- HER2/EGFR in Cancer Research 4
-
- Cell death mechanisms and regulation 10
- Co-authors
- Rajani Ravi (20 shared papers)Bijoyesh Mookerjee (3 shared papers)Qinwen Zeng (3 shared papers)Dmitri Artemov (3 shared papers)Gregg L. Semenza (3 shared papers)Zaver M. Bhujwalla (3 shared papers)Larry E. Dillehay (2 shared papers)Ashima Madan (2 shared papers)
- Journals
- Cancer Research (5 papers)Nature Communications (2 papers)PLoS ONE (2 papers)Current Opinion in Oncology (2 papers)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- United StatesRussiaSpain
In The Last Decade
Atul Bedi
29 papers receiving 4.7k citations
Atul Bedi's Hit Papers
Peers
Comparison fields: 5 of 117
- Cancer Research 2.0k
- Oncology 1.6k
- Molecular Biology 3.2k
- Immunology 639
- Biotechnology 234
Countries citing papers authored by Atul Bedi
This map shows the geographic impact of Atul Bedi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atul Bedi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atul Bedi more than expected).
Fields of papers citing papers by Atul Bedi
This network shows the impact of papers produced by Atul Bedi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atul Bedi. The network helps show where Atul Bedi may publish in the future.
Co-authors
The 25 scholars most cited alongside Atul Bedi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Conversion of Bcl-2 to a Bax-like Death Effector by Caspases Hit paper breakdown → | 1997 | 943 |
| 2 | Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. Hit paper breakdown → | 2000 | 942 |
| 3 | Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α Hit paper breakdown → | 2000 | 831 |
| 4 | 2001 | 269 | |
| 5 | 2018 | 250 | |
| 6 | 1995 | 212 | |
| 7 | 2001 | 167 | |
| 8 | 1996 | 139 | |
| 9 | p53-dependent DNA damage-induced apoptosis requires Fas/APO-1-independent activation of CPP32beta. | 1997 | 118 |
| 10 | Requirement of BAX for TRAIL/Apo2L-induced apoptosis of colorectal cancers: synergism with sulindac-mediated inhibition of Bcl-x(L). | 2002 | 111 |
| 11 | 2014 | 104 | |
| 12 | 2015 | 101 | |
| 13 | Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II. | 2002 | 89 |
| 14 | 2004 | 63 | |
| 15 | 2012 | 59 | |
| 16 | 2017 | 57 | |
| 17 | Growth factor-mediated terminal differentiation of chronic myeloid leukemia. | 1994 | 46 |
| 18 | 2015 | 41 | |
| 19 | 2011 | 38 | |
| 20 | 2006 | 37 |
About Atul Bedi
Atul Bedi is a scholar working on Oncology, Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine and Immunology, having authored 29 papers that have together received 4.8k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (10 papers), Cancer-related Molecular Pathways (8 papers), Lung Cancer Treatments and Mutations (6 papers), Colorectal Cancer Treatments and Studies (4 papers), HER2/EGFR in Cancer Research (4 papers), interferon and immune responses (4 papers), NF-κB Signaling Pathways (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). The work is most often cited by research in Cancer Research (2.0k citations), Oncology (1.6k citations), Molecular Biology (3.2k citations), Immunology (639 citations) and Biotechnology (234 citations). Atul Bedi has collaborated with scholars based in United States, Russia and Spain. Frequent co-authors include Rajani Ravi, Bijoyesh Mookerjee, Qinwen Zeng, Dmitri Artemov, Gregg L. Semenza, Zaver M. Bhujwalla, Larry E. Dillehay, Ashima Madan, Thomas R. Sutter and Michael B. Kastan. Their work appears in journals such as Cancer Research, Nature Communications, PLoS ONE, Current Opinion in Oncology and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.